Castle Biosciences works with providers to secure coverage
The decision to undergo prognostic testing is one to make after a full discussion with your doctor. If you decide you want the information the GEP test provides, it’s important to know that Castle Biosciences has, to date, processed all DecisionDx™-UM test orders for U.S.-based physicians regardless of the patient’s ability to pay.
Castle Biosciences works with Medicare, commercial insurance providers and, in some cases, your physician’s institution to secure payment coverage for DecisionDx-UM. Castle submits insurance claims on your behalf and follows through the system to payment. The Company believes a patient’s ability to pay for the test should not affect their care, and has put a generous Patient Assistance Program in place for those who need it.